Rein Therapeutics Inc.

Rein Therapeutics Inc.verified

RNTX

Price:

$1.39

Market Cap:

$36.54M

Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. The company was founded by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky on August 6, 2001 and is headquartered in Austin, TX.

Industry

Medical - Pharmaceuticals

IPO Date

2017-06-29

Stock Exchange

NASDAQ

Ticker

RNTX

The PE Ratio as of December 2025 (TTM) for Rein Therapeutics Inc. (RNTX) is -0.47

According to Rein Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.47. This represents a change of -27.68% compared to the average of -0.65 of the last 4 quarters.

Rein Therapeutics Inc. (RNTX) Historical PE Ratio (quarterly & annually)

How has RNTX PE Ratio performed in the past?

The mean historical PE Ratio of Rein Therapeutics Inc. over the last ten years is -174.79. The current -0.47 PE Ratio has changed -73.11% with respect to the historical average. Over the past ten years (40 quarters), RNTX's PE Ratio was at its highest in in the March 2016 quarter at 0. The PE Ratio was at its lowest in in the September 2024 quarter at -1.96.

Quarterly (TTM)
Annual

Average

-174.79

Median

-0.00

Minimum

-1746.54

Maximum

0

Rein Therapeutics Inc. (RNTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Rein Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = 0%

Minimum Annual PE Ratio = -1746.54

Quarterly (TTM)
Annual
YearPE RatioChange
2024-0.00-99.89%
2023-0.6275.97%
2022-0.35-2.13%
2021-0.36-99.98%
2020-1746.54-Infinity%
201900%
201800%
201700%
201600%

Rein Therapeutics Inc. (RNTX) Average PE Ratio

How has RNTX PE Ratio performed in the past?

The current PE Ratio of Rein Therapeutics Inc. (RNTX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.32

5-year avg

-349.57

10-year avg

-174.79

Rein Therapeutics Inc. (RNTX) PE Ratio vs. Peers

How is RNTX’s PE Ratio compared to its peers?

Rein Therapeutics Inc.’s PE Ratio is less than Inotiv, Inc. (-0.36), greater than HeartBeam, Inc. (-1.20), greater than 111, Inc. (-3.12), less than Tempest Therapeutics, Inc. (-0.30), greater than BioAtla, Inc. (-1.02), greater than Kezar Life Sciences, Inc. (-0.65), greater than Celularity Inc. (-0.64), greater than Actinium Pharmaceuticals, Inc. (-1.31), greater than Mersana Therapeutics, Inc. (-1.95), greater than Quantum BioPharma Ltd. (-1.12),

Build a custom stock screener for Rein Therapeutics Inc. (RNTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rein Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rein Therapeutics Inc. (RNTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rein Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Rein Therapeutics Inc.'s PE Ratio?

How is the PE Ratio calculated for Rein Therapeutics Inc. (RNTX)?

What is the highest PE Ratio for Rein Therapeutics Inc. (RNTX)?

What is the 3-year average PE Ratio for Rein Therapeutics Inc. (RNTX)?

What is the 5-year average PE Ratio for Rein Therapeutics Inc. (RNTX)?

How does the current PE Ratio for Rein Therapeutics Inc. (RNTX) compare to its historical average?